MDTvsSYK
Medtronic PLCvsStryker Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.
Medtronic PLC
$83.79
-14.76%
Stryker Corp
$329.65
-6.27%
60-day price, rebased to 100
Round-by-round
Valuation upside
-26.00% vs -33.60% to DCF fair value
Balance-sheet strength
Altman Z 2.76 vs 4.61
Fundamental quality
Piotroski 3.00 vs 5.00 (of 9)
Growth + margins
Rule-of-40 15.50 vs 28.20
60-day momentum
-18.42% vs -10.80% price return
Market-cap liquidity
$111.2B vs $125.4B
Verdict
Across6categories,SYKtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.
Backtest a strategy onMDTorSYK
Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.